Strand 1 - a) C-Reactive Protein PoC Testing b) Polypharmacy and non-prescribed Medicines
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Strand 1 - a) C-Reactive Protein PoC Testing b) Polypharmacy and non-prescribed Medicines | |||
| Speakers | a) Integration of C-Reactive Protein Point of Care Testing in General Practice to Reduce Antimicrobial Prescribing Seldon, S*, Hood, S**, Fletcher, J* * NHS Sunderland Clinical Commissioning Group ** Derwentside Health Care Federation b) Polypharmacy and non-prescribed medicines Oladaop Ogunbayo, Institute of Health and Society (IHS), Newcastle University | |||
| Satellite Description | ||||
|
13:45 - 14:05 Integration of C-Reactive Protein Point of Care Testing in General Practice to Reduce Antimicrobial Prescribing The NICE Guidance on Pneumonia (CG191) and Antimicrobial Stewardship (AMS) (QS121) have advocated the use of Point of Care (POC) C-Reactive Protein (CRP) testing to reduce antimicrobial prescribing for respiratory tract infections (RTI), many of which are self-limiting but are known to attract prescriptions for antimicrobials. NHS Sunderland Clinical Commissioning Group (SCCG) decided to explore use of CRP POC testing as a potential solution to reduce unnecessary antimicrobial prescribing. However, challenges are known to exist in the implementation and integration of such new diagnostic technologies. SCCG medicines optimisation (MO) team commissioned a pilot programme with the aim of integrating CRP POCT into general practice. The programme was found to influence prescribing decisions and support prescribing behaviour change. Patient experience of the programme was positive, with 99% reporting that the CRP POC test was beneficial. This presentation will discuss the implementation and evaluation of the pilot, and the resulting novel strategy instigated by the MO team to embed behaviour change and allow maximum access to the diagnostic technology across all 40 GP practices within Sunderland.
14:05 - 14:25 Polypharmacy and non-prescribed medicines Title: How do non-prescribed medicines (NPMs) contribute to polypharmacy in older adults with multimorbidity? With increasing life expectancy, the number of people with complex chronic health conditions is on the rise. Multiple medicines (polypharmacy) are needed to treat these conditions but there are concerns about adverse consequences of unnecessary or inappropriate polypharmacy. While the use of prescribed medicines is the main predictor of polypharmacy, there are knowledge gaps around the increasing use of non-prescribed medicines (NPMs) obtained via self-medication with over-the-counter, herbal and other medicines. The adverse consequences of NPMs use may be even greater for older, frail adults who are on numerous prescribed medicines and experiencing cognitive and functional impairments and other geriatric syndromes. This ongoing programme of work aims to understand the contribution of NPMs to polypharmacy among older adults with multimorbidity. The first work-stream is a systematic literature review undertaken to identify and synthesise current evidence around NPMs use among older adults. The second work-stream consists of secondary data analyses of a longitudinal population-level dataset to investigate trends and factors associated with NPM use and associations with variables such as sociodemographic, disease and health status and health service use. This presentation will detail key findings and discuss implications for clinicians and policymakers on strategies that go beyond review of prescribed medicines.
| ||||
